Announcing the results of the 2026 INFORMS Board of Directors election and the new board for 2027.
INFORMS has named 12 distinguished leaders as the 2026 class of INFORMS Fellows, one of the highest honors in the profession.
Most medical devices do not hit the market through rigorous safety testing but by being deemed similar enough to something already approved—the “predicate” device through a mechanism known as the FDA’s 510(k) pathway. But similar is not a synonym for safe. While the assumption may be that substantial equivalence is a reasonable stand-in for a safety review, a share of devices cleared with this method still get recalled, and the FDA spends valuable time reviewing devices the same way, regardless of how risky it is on paper.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
A Wisconsin medical leader says COVID-19 cases and hospitalizations are trending in the wrong direction.
According to a public filing Friday, Robert Kramer, CEO of Emergent BioSolutions, received a 51 percent increase in total compensation in 2020, to $5.6 million, before the company ruined 15 million doses of the Johnson & Johnson vaccine, according to The Washington Post. According to the report, the vaccine had been contaminated with ingredients of the AstraZeneca vaccine.
This limited series was created in honor of Supply & Demand Chain Executive magazine's 20-year anniversary. This professional development podcast includes interviews with supply chain students, young professionals, veterans, and professors who detail training, recruitment, retention, and the evolution of education in the supply chain.
Maryland health officials expect to see a drastic reduction in the state’s allocation of Johnson & Johnson’s COVID-19 vaccine next week — a shortfall that will lead to a 33% drop overall in the availability of first- or single-dose vaccines compared to this week, officials said.
COVID-19 exposed risks and spurred conversations about moving manufacturing, but the pandemic is far from the only factor to consider.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine